| Contraception |
1 |
1 |
| Sterilization, Birth Control |
0 |
0.99 |
| Birth |
0 |
0.61 |
| Pregnancy |
0 |
0.5 |
| Revenue and Practice Management |
0 |
0.98 |
| Acne |
0 |
0.27 |
| Insurance |
0 |
0.22 |
| Health Insurance |
0 |
0.2 |
| Rosacea |
0 |
0.2 |
| Thromboembolism |
0 |
0.19 |
| Isotretinoin |
0 |
0.17 |
| Washington |
0 |
0.17 |
| Washington DC |
0 |
0.16 |
| Adolescent Medicine |
0 |
0.11 |
| Estrogen |
0 |
0.11 |
| Health Plans |
0 |
0.11 |
| Michigan |
0 |
0.11 |
| Nurse Practitioners |
0 |
0.11 |
| Progestin |
0 |
0.11 |
| Salary and Compensation |
0 |
0.11 |
| Sexually Transmitted Infection |
0 |
0.11 |
| Venous Thromboembolism (VTE) |
0 |
0.1 |
| Heart Failure (HF) |
0 |
0.08 |
| Pulmonary Arterial Hypertension |
0 |
0.08 |
| Vaginal Hemorrhage |
0 |
0.08 |
| Adverse Effects |
0 |
0.06 |
| California |
0 |
0.06 |
| Food and Drug Administration (FDA) |
0 |
0.06 |
| Hypertension |
0 |
0.06 |
| Medicaid |
0 |
0.06 |
| New Mexico |
0 |
0.06 |
| New York |
0 |
0.06 |
| Patient Safety |
0 |
0.06 |
| Primary Care |
0 |
0.06 |
| Pulmonary Hypertension |
0 |
0.06 |
| Seizure |
0 |
0.06 |
| Skin and Soft Tissue Infection |
0 |
0.06 |
| Thrombosis |
0 |
0.06 |
| Tuberculosis |
0 |
0.06 |
| Vagina |
0 |
0.06 |